Aisleen McColl-Carboni

Aisleen McColl-Carboni has over 15 years of work experience in the biotech and pharmaceutical industry. Aisleen'smost recent position is as a Senior Director at Oxford Biomedica Solutions, where they have been since January 2023. Prior to that, they worked as a Director at the same company starting in March 2022. Before joining Oxford Biomedica Solutions, Aisleen was employed at Homology Medicines, Inc. as a Director from July 2021 to March 2022, and as an Associate Director from December 2019 to July 2021. Aisleen also has experience working at Sanofi as a Senior Scientist from November 2016 to December 2019, and at Biogen as a Scientist, Technical Development from January 2014 to November 2016. Aisleen's earlier career includes roles as a Postdoctoral Fellow at Massachusetts General Hospital from October 2011 to 2013 and at Harvard School of Public Health from September 2009 to July 2011. Aisleen began their career as a Ph.D student at The University of Edinburgh from January 2006 to September 2009. Aisleen also has research experience as an Undergraduate Student at the University of Glasgow in 2004. Throughout their career, they have demonstrated expertise in various areas including assay development, cell-based assays, analytical methods, and molecular biology.

Aisleen McColl-Carboni completed their education with a Bachelor's degree in Immunology from the University of Glasgow, where they earned this qualification between 2001 and 2005. Subsequently, they pursued further studies and obtained a Doctor of Philosophy (Ph.D.) degree in Immunology from The University of Edinburgh, which they successfully completed in the period from 2006 to 2009.